Abstract
Background and Objective: Determining the efficiency of kidney transplantation, the survival rate of patients after surgery, and the role of factors affecting this survival is of particular importance. The present study aimed to assess the survival rate of recipients of cadaveric-donor kidneys in the transplant unit of Imam Reza (AS) Hospital in Tabriz during the last five years. Materials and Methods: This descriptive-analytical study was conducted on the recipients of cadaveric-donor kidneys. The data were collected from documents of donor patients, evaluation of blood and urine tests, and follow-up. The required examinations included height, weight, body mass index, age of recipient and donor, blood group, and RH of donor and recipient, donor-recipient kinship, duration of dialysis, year of transplantation, duration of transplantation, duration of patient survival, other drugs (aspirin, heart, hypertension, and cholesterol-lowering medications). Results: In the present study, the survival rates of kidney transplantation at 1, 2, 3, and 5 years were 97%, 90.9%, 79.1%, and 67%, respectively. Moreover, 1, 2, 3, and 5-year survival rates of patients were reported as 98%, 95.5%, 90.9% and 87.4%, respectively. Furthermore, gender and age of kidney donor and recipient were not significantly correlated with renal transplant survival. Conclusion: Kidney transplantation is the most appropriate treatment option for end-stage renal disease patients, leading to better survival and improved quality of life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.